Nuvectis Pharma (NVCT) Stock Price, Quote, News & History | Benzinga

SPY779.87+0.10%QQQ759.84+0.02%BTC/USD84,282.49−1.48%DIA514.66+0.02%GLD381.90−0.10%TLT77.20−0.10%

Nuvectis Pharma Inc (NVCT) Stock Price, Quote, News & History

NVCTNASDAQ

Trade with Public

Trade with Public

$20.03

-1.36-6.36%

Last update: Oct 6, 4:00 PM

$20.03

-1.36-6.36%

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$21.54

Close

$20.03

Volume / Avg.

188.08K / 236.02K

Day Range

$19.79 - $21.54

52 Wk Range

5.55 - 29.28

Market Cap

$653.86M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

42

Short Interest

10.88%

Days to Cover

14.77

Recent Nuvectis Pharma Inc News

This Cal-Maine Foods Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday

Analysts downgraded UiPath, Cal-Maine with several price-target cuts.

Avi Kapoor

This Toast Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Wednesday

Wall Street analysts changed outlook on top companies. Check out complete rating changes, including upgrades/downgrades, on our page.

Avi Kapoor

This PG&E Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. BMO Capital

Avi Kapoor

This Sempra Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Mizuho analyst

Avi Kapoor

This Deere Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Baird analyst

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-19.51M

Investing Cash Flow (TTM)

0

Financing Cash Flow (TTM)

14.88M

Free Cash Flow (TTM)

-19.51M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-4.63M

Analyst Trends and Forecast

2

Jun

1

Jul

1

Aug

1

Sep

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$631.70M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

72.00

Earnings Yield % (TTM)

-6.59%

Earnings Yield % (FWD)

-4.64%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.28

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$22.16M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-